T-CELL LYMPHOMA

Clinical trials for T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New drug may help prevent T-Cell lymphoma relapse after transplant

Disease control Ongoing

This study tests whether the drug duvelisib can safely keep T-cell lymphoma from coming back after a stem cell transplant. About 17 adults with certain types of T-cell lymphoma will take duvelisib after their transplant. The goal is to see if this approach improves how long peopl…

Matched conditions: T-CELL LYMPHOMA

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Apr 29, 2026 06:56 UTC

T-CELL LYMPHOMA

Get alerted when new T-CELL LYMPHOMA trials appear

New drug may help prevent T-Cell lymphoma relapse after transplant